127 related articles for article (PubMed ID: 36918057)
1. Quantitative Image Analysis of Fibrillar Collagens Reveals Novel Diagnostic and Prognostic Biomarkers and Histotype-Dependent Aberrant Mechanobiology in Lung Cancer.
Almici E; Arshakyan M; Carrasco JL; Martínez A; Ramírez J; Enguita AB; Monsó E; Montero J; Samitier J; Alcaraz J
Mod Pathol; 2023 Jul; 36(7):100155. PubMed ID: 36918057
[TBL] [Abstract][Full Text] [Related]
2. Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer.
Alcaraz J; Carrasco JL; Millares L; Luis IC; Fernández-Porras FJ; Martínez-Romero A; Diaz-Valdivia N; De Cos JS; Rami-Porta R; Seijo L; Ramírez J; Pajares MJ; Reguart N; Barreiro E; Monsó E
Lung Cancer; 2019 Sep; 135():151-160. PubMed ID: 31446988
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Luo X; Zang X; Yang L; Huang J; Liang F; Rodriguez-Canales J; Wistuba II; Gazdar A; Xie Y; Xiao G
J Thorac Oncol; 2017 Mar; 12(3):501-509. PubMed ID: 27826035
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Picrosirius Red Staining With Second Harmonic Generation Imaging for the Quantification of Clinically Relevant Collagen Fiber Features in Histopathology Samples.
Drifka CR; Loeffler AG; Mathewson K; Mehta G; Keikhosravi A; Liu Y; Lemancik S; Ricke WA; Weber SM; Kao WJ; Eliceiri KW
J Histochem Cytochem; 2016 Sep; 64(9):519-29. PubMed ID: 27449741
[TBL] [Abstract][Full Text] [Related]
5. Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.
Hlaing AM; Furusato B; Udo E; Kitamura Y; Souda M; Masutani M; Fukuoka J
Biochem Biophys Res Commun; 2018 Sep; 503(4):2764-2769. PubMed ID: 30100056
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples.
Casadevall D; Clavé S; Taus Á; Hardy-Werbin M; Rocha P; Lorenzo M; Menéndez S; Salido M; Albanell J; Pijuan L; Arriola E
Clin Lung Cancer; 2017 Nov; 18(6):682-691.e5. PubMed ID: 28549836
[TBL] [Abstract][Full Text] [Related]
7. Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancer.
Spivey KA; Banyard J; Solis LM; Wistuba II; Barletta JA; Gandhi L; Feldman HA; Rodig SJ; Chirieac LR; Zetter BR
Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1362-72. PubMed ID: 20447926
[TBL] [Abstract][Full Text] [Related]
8. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
[TBL] [Abstract][Full Text] [Related]
9. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
Feng A; Tu Z; Yin B
Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
[TBL] [Abstract][Full Text] [Related]
10. SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.
Han F; Zhang MQ; Liu WB; Sun L; Hao XL; Yin L; Jiang X; Cao J; Liu JY
Respir Res; 2018 Dec; 19(1):241. PubMed ID: 30514297
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients.
Zhang X; Li P; Rong M; He R; Hou X; Xie Y; Chen G
Tohoku J Exp Med; 2015 Mar; 235(3):161-9. PubMed ID: 25746592
[TBL] [Abstract][Full Text] [Related]
12. Low PD-1 Expression in Cytotoxic CD8
Mazzaschi G; Madeddu D; Falco A; Bocchialini G; Goldoni M; Sogni F; Armani G; Lagrasta CA; Lorusso B; Mangiaracina C; Vilella R; Frati C; Alfieri R; Ampollini L; Veneziani M; Silini EM; Ardizzoni A; Urbanek K; Aversa F; Quaini F; Tiseo M
Clin Cancer Res; 2018 Jan; 24(2):407-419. PubMed ID: 29074606
[No Abstract] [Full Text] [Related]
13. Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: Local patterns and prognostic significance.
Millares L; Barreiro E; Cortes R; Martinez-Romero A; Balcells C; Cascante M; Enguita AB; Alvarez C; Rami-Porta R; Sánchez de Cos J; Seijo L; Monsó E;
Lung Cancer; 2018 Aug; 122():124-130. PubMed ID: 30032820
[TBL] [Abstract][Full Text] [Related]
14. Expression of DR5 and c‑FLIP proteins as novel prognostic biomarkers for non‑small cell lung cancer patients treated with surgical resection and chemotherapy.
Zheng H; Zhang Y; Zhan Y; Liu S; Lu J; Wen Q; Fan S
Oncol Rep; 2019 Dec; 42(6):2363-2370. PubMed ID: 31638235
[TBL] [Abstract][Full Text] [Related]
15. Significance of EpCAM and TROP2 expression in non-small cell lung cancer.
Pak MG; Shin DH; Lee CH; Lee MK
World J Surg Oncol; 2012 Apr; 10():53. PubMed ID: 22482828
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
17. Matrix stiffening and β1 integrin drive subtype-specific fibroblast accumulation in lung cancer.
Puig M; Lugo R; Gabasa M; Giménez A; Velásquez A; Galgoczy R; Ramírez J; Gómez-Caro A; Busnadiego Ó; Rodríguez-Pascual F; Gascón P; Reguart N; Alcaraz J
Mol Cancer Res; 2015 Jan; 13(1):161-73. PubMed ID: 25280968
[TBL] [Abstract][Full Text] [Related]
18. Notch Signaling Components: Diverging Prognostic Indicators in Lung Adenocarcinoma.
Liu ZY; Wu T; Li Q; Wang MC; Jing L; Ruan ZP; Yao Y; Nan KJ; Guo H
Medicine (Baltimore); 2016 May; 95(20):e3715. PubMed ID: 27196489
[TBL] [Abstract][Full Text] [Related]
19. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer.
Wen Q; Zhan Y; Zheng H; Zang H; Luo J; Zhang Y; Wang W; Feng J; Lu J; Chen L; Fan S
Diagn Pathol; 2019 Oct; 14(1):108. PubMed ID: 31601252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]